RepliCel Life Sciences Announces Closing of Brokered and Non-brokered Private Placement Biotech Investing
Revive Therapeutics Announces Term Sheet with InMed Pharmaceuticals for the Discovery and Development of Cannabinoid-Based Therapy Targeting Kidney Diseases Cannabis Investing News
Upon Successful Completion of Cohort 3, Cellectar Biosciences Initiates Fourth Cohort of Its Phase I Clinical Trial of CLR 131 in Multiple Myeloma Biotech Investing
Inspyr Therapeutics Initiates Mipsagargin Combination Therapy Program for Gastric Cancer Biotech Investing
